AN2 Therapeutics (ANTX)
(Delayed Data from NSDQ)
$1.02 USD
-0.01 (-0.97%)
Updated Sep 6, 2024 04:00 PM ET
After-Market: $1.02 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
D Value D Growth A Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/14/2024
Time: -- |
9/2024 | $-0.42 | 0.00% |
Earnings Summary
For their last quarter, AN2 Therapeutics (ANTX) reported earnings of -$0.48 per share, beating the Zacks Consensus Estimate of $-0.63 per share. This reflects a positive earnings surprise of 23.81%. Look out for ANTX's next earnings release expected on November 14, 2024. For the next earning release, we expect the company to report earnings of -$0.42 per share, reflecting a year-over-year increase of 35.38%.
Earnings History
Price & Consensus
Zacks News for ANTX
Down -5.51% in 4 Weeks, Here's Why AN2 Therapeutics (ANTX) Looks Ripe for a Turnaround
ANTX: What are Zacks experts saying now?
Zacks Private Portfolio Services